Activation of Stat3 by v-Src is through a Ras-independent pathway

Journal of Biomedical Science

Volumn 5, Issue 6, 1998, Pages 446-450

  Liu, Jan Jan ^a,b   Nakajima, Koichi ^c   Hirano, Toshio ^c   Yang Yen, Hsin Fang ^a,b  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Jak1; Ras; Signaling molecules; Star3; V Src

Indexed keywords

GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RAS PROTEIN; STAT3 PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE RAS; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0031742128     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000025360     Document Type: Article

References (31)

1. Barone MV, Courtneidge SA. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512;1995.
2. Bollag G, McCormick F. Regulators and effectors of ras proteins. Annu Rev Cell Biol 7:601-632;1991.
3. Bromberg JF, Horvath CM, Besser D, Lathem WW, Damell JE Jr. Stat 3 activation is required for cellular transformation by v-src. Mol Cell Biol 18:2553-2558;1998.
4. Campbell GS, Yu CL, Jove R, Carter-Su, C. Constitutive activation of JAK1 in Src-transformed cells. J Biol Chem 272:2591-2594; 1997.
5. Cao X, Tay A, Guy GR, Tan YH. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol 16:1595-1603; 1996.
6. Chao JR, Chen CS, Wang TF, Tseng LH, Tsai JJ, Kuo ML, Yen JJY, Yang-Yen HF. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: The role of the Raf/MAP kinase pathway in the ami-apoptotic effect of GM-CSF. Oncogene 14:721-728:1997.
7. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 7:176-182; 1995.
8. Feig LA, Cooper GM. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243;1988.
9. Frank DA, Robertson MJ, Bonni A, Ritz J, Greenberg ME. Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc Natl Acad Sci 92:7779-7783;1995.
10. Fukui Y, Hanafusa H. Requirement of phosphatidylinositol-3 kinase modification for its association with p60src. Mol Cell Biol 11: 1972-1979;1991.
11. Ihle JN STATs: Signal transducers and activators of transcription. Cell 84:331-334;1996.
12. Ihle JN, Kerr IM. Jaks and Stats in signaling by the cytokine receptor. Trends Genet 11:69-74; 1995.
13. Komatsu N, Adamson JW, Yamamoto K, Altschuler D, Torti M, Marzocchini R, Lapetina EG. Erythropoietin rapidly induces tyrosine phosphorylation in the human erythropoietin-dependent cell line, UT-7. Blood 80:53-59; 1992.
14. Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJY, Yang-Yen HF. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 15:3654-3663;1995.
15. Marshall CJ. Ras effectors. Curr Opin Cell Biol 8:197-204;1996.
16. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol 10:295-331; 1992.
17. Nagata S. Apoptosis by death factor. Cell 88: 355-365;1997.
18. Nakafuku M, Satoh T, Kaziro Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras. GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 267:19448-19454;1992.
19. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in MI leukemia cells. EMBO J 15: 3651-3658;1996.
20. Ram PA, Waxman DJ. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272:17694-17702;1997.
21. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD. Downward J. Phosphatidylinosuol-3-OH-kinase as a direct target of Ras. Nature 370:527-532;1994.
22. Satoh T, Nakafuku M, Miyajima A, Kaziro Y. Involvement of ras p21 protein in signal-trans duction pathways from interleukin 2. interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314-3318;1991.
23. Schindler C, Damell JE Jr. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64:621-651;1995.
24. Silvennoinen O, Schindler C, Schlessinger J, Levy DE. Ras-independent growth factor signaling by transcription factor tyrosine phosphorlyation. Science 261:1736-1739;1993.
25. Smith MR, DeGudicibus SJ, Stacey DW. Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543; 1986.
26. Stacey DW, Roudebush M, Day R, Mosser SD, Gibbs JB, Feig LA. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6:2297-2304;1991.
27. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18:2545-2552;1998.
28. Yang CH, Shi W, Basu L, Murti A, Constantinescu SN, Blatt L, Croze E, Mullersman JE, Pfeffer LM. Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor. J Biol Chem 271:8057-8061; 1996.
29. Yu CL, Meyer DJ, Campbell GS, Lamer AC, Carter-Su C, Schwanz J, Jove R. Enhanced DNA-bindmg activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269:81-83;1995.
30. Zang Q, Frankel P, Foster DA. Selective activation of protein kinase C isoforms by v-Src. Cell Growth Differ 6:1367-1373;1995.
31. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98; 1994.